Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081924118> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3081924118 abstract "OBJECTIVE <p>We examined the impact of acarbose, an alpha-glucosidase inhibitor, on incident diabetes and regression to normoglycemia in 6,522 Acarbose Cardiovascular Evaluation trial participants in China who had impaired glucose tolerance (IGT) and coronary heart disease (CHD).</p> <p>RESEARCH DESIGN AND METHODS</p> <p>Participants were randomly assigned to acarbose or placebo and followed with four-monthly FPGs and annual OGTTs. Incident diabetes was defined as two successive diagnostic FPGs ≥ 7 mmol/L or 2-hr PGs ≥ 11.1 mmol /L while taking study medication, or a masked adjudicated confirmation of this diagnosis. Regression to normoglycemia was defined as FPG <6.1 mmol/L and 2-hr PG <7.8 mmol/L. Intention-to-treat and on-treatment analyses were conducted using Poisson regression models, overall and for subgroups (age, sex, CHD type, HbA<sub>1c</sub>, FPG, 2h-PG, BMI eGFR), for IGT alone and for IGT+IFG, and for use of thiazides, ACE inhibitors/angiotensin receptor blockers, beta blockers, calcium channel blockers or statins). </p> <p>RESULTS</p> <p>Incident diabetes was less frequent with acarbose, compared with placebo, being 3.2 and 3.8 <i>per</i> 100 person-years respectively (rate ratio (RR) 0.82, 95%CI 0.71–0.94, p=0.005), with no evidence of differential effects within the predefined subgroups after accounting for multiple testing. Regression to normoglycemia occurred more frequently in those randomized to acarbose, compared with placebo, being 16.3 and 14.1 <i>per</i> 100 person-years respectively (RR 1.16, 95%CI 1.08–1.25, p<0.0001). This effect was greater in participants not taking an ACEi or ARB (RR 1.36, 95%CI 1.21–1.53; P<sub>interaction</sub>=0.0006). The likelihood of remaining in normoglycemic regression did not differ between acarbose and placebo groups (P=0.41).</p> <p>CONCLUSIONS</p> <p>Acarbose reduced the incidence of diabetes and promoted regression to normoglycemia in Chinese people with IGT and CHD. </p>" @default.
- W3081924118 created "2020-09-08" @default.
- W3081924118 creator A5009082804 @default.
- W3081924118 creator A5014172894 @default.
- W3081924118 creator A5032244539 @default.
- W3081924118 creator A5049740900 @default.
- W3081924118 creator A5060545924 @default.
- W3081924118 creator A5080912918 @default.
- W3081924118 creator A5088746818 @default.
- W3081924118 date "2020-07-08" @default.
- W3081924118 modified "2023-09-27" @default.
- W3081924118 title "Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People with Coronary Heart Disease and Impaired Glucose Tolerance: Insights from the ACE Trial" @default.
- W3081924118 doi "https://doi.org/10.2337/figshare.12466562.v1" @default.
- W3081924118 hasPublicationYear "2020" @default.
- W3081924118 type Work @default.
- W3081924118 sameAs 3081924118 @default.
- W3081924118 citedByCount "1" @default.
- W3081924118 countsByYear W30819241182022 @default.
- W3081924118 crossrefType "posted-content" @default.
- W3081924118 hasAuthorship W3081924118A5009082804 @default.
- W3081924118 hasAuthorship W3081924118A5014172894 @default.
- W3081924118 hasAuthorship W3081924118A5032244539 @default.
- W3081924118 hasAuthorship W3081924118A5049740900 @default.
- W3081924118 hasAuthorship W3081924118A5060545924 @default.
- W3081924118 hasAuthorship W3081924118A5080912918 @default.
- W3081924118 hasAuthorship W3081924118A5088746818 @default.
- W3081924118 hasBestOaLocation W30819241181 @default.
- W3081924118 hasConcept C126322002 @default.
- W3081924118 hasConcept C134018914 @default.
- W3081924118 hasConcept C142724271 @default.
- W3081924118 hasConcept C204787440 @default.
- W3081924118 hasConcept C27081682 @default.
- W3081924118 hasConcept C2776617576 @default.
- W3081924118 hasConcept C2777180221 @default.
- W3081924118 hasConcept C2777185836 @default.
- W3081924118 hasConcept C2780609358 @default.
- W3081924118 hasConcept C2908647359 @default.
- W3081924118 hasConcept C555293320 @default.
- W3081924118 hasConcept C71924100 @default.
- W3081924118 hasConcept C73269764 @default.
- W3081924118 hasConcept C90924648 @default.
- W3081924118 hasConcept C99454951 @default.
- W3081924118 hasConceptScore W3081924118C126322002 @default.
- W3081924118 hasConceptScore W3081924118C134018914 @default.
- W3081924118 hasConceptScore W3081924118C142724271 @default.
- W3081924118 hasConceptScore W3081924118C204787440 @default.
- W3081924118 hasConceptScore W3081924118C27081682 @default.
- W3081924118 hasConceptScore W3081924118C2776617576 @default.
- W3081924118 hasConceptScore W3081924118C2777180221 @default.
- W3081924118 hasConceptScore W3081924118C2777185836 @default.
- W3081924118 hasConceptScore W3081924118C2780609358 @default.
- W3081924118 hasConceptScore W3081924118C2908647359 @default.
- W3081924118 hasConceptScore W3081924118C555293320 @default.
- W3081924118 hasConceptScore W3081924118C71924100 @default.
- W3081924118 hasConceptScore W3081924118C73269764 @default.
- W3081924118 hasConceptScore W3081924118C90924648 @default.
- W3081924118 hasConceptScore W3081924118C99454951 @default.
- W3081924118 hasLocation W30819241181 @default.
- W3081924118 hasOpenAccess W3081924118 @default.
- W3081924118 hasPrimaryLocation W30819241181 @default.
- W3081924118 hasRelatedWork W10261008 @default.
- W3081924118 hasRelatedWork W18722868 @default.
- W3081924118 hasRelatedWork W19680406 @default.
- W3081924118 hasRelatedWork W20691378 @default.
- W3081924118 hasRelatedWork W2776280 @default.
- W3081924118 hasRelatedWork W5243670 @default.
- W3081924118 hasRelatedWork W5969576 @default.
- W3081924118 hasRelatedWork W738392 @default.
- W3081924118 hasRelatedWork W9343845 @default.
- W3081924118 hasRelatedWork W16605058 @default.
- W3081924118 isParatext "false" @default.
- W3081924118 isRetracted "false" @default.
- W3081924118 magId "3081924118" @default.
- W3081924118 workType "article" @default.